Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Truntzer

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|August 22, 2024
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, <i>KEAP1/STK11</i> co-mutated metastatic NSCLCNicolas Roussot, Marion Thibaudin, Jean-David Fumet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2026
Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049]Valentin Derangère, Julie Lecuelle, Come Lepage, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2022
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancerValentin Derangère, Julie Lecuelle, Come Lepage, et al.
Nature Medicine|August 10, 2023
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trialMarion Thibaudin, Jean-David Fumet, Benoist Chibaudel, et al.
Ebiomedicine|January 11, 2020
Implementation and use of whole exome sequencing for metastatic solid cancerManon Réda, Corentin Richard, Aurelie Bertaut, et al.
British Journal of Cancer|October 16, 2018
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapyJean-David Fumet, Corentin Richard, Fanny Ledys, et al.
Nature Communications|June 2, 2026
The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancerHussein Issaoui, Lina Zawil, Lola Bellone, et al.
British Journal of Cancer|June 26, 2019
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapyJean-David Fumet, Corentin Richard, Fanny Ledys, et al.
Cancer Cell|January 20, 2022
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cellsEmeric Limagne, Lisa Nuttin, Marion Thibaudin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2022
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional studySylvain Ladoire, Emilie Rederstorff, Vincent Goussot, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|August 22, 2024
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, <i>KEAP1/STK11</i> co-mutated metastatic NSCLCNicolas Roussot, Marion Thibaudin, Jean-David Fumet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2026
Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049]Valentin Derangère, Julie Lecuelle, Come Lepage, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2022
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancerValentin Derangère, Julie Lecuelle, Come Lepage, et al.
Nature Medicine|August 10, 2023
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trialMarion Thibaudin, Jean-David Fumet, Benoist Chibaudel, et al.
Ebiomedicine|January 11, 2020
Implementation and use of whole exome sequencing for metastatic solid cancerManon Réda, Corentin Richard, Aurelie Bertaut, et al.
British Journal of Cancer|October 16, 2018
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapyJean-David Fumet, Corentin Richard, Fanny Ledys, et al.
Nature Communications|June 2, 2026
The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancerHussein Issaoui, Lina Zawil, Lola Bellone, et al.
British Journal of Cancer|June 26, 2019
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapyJean-David Fumet, Corentin Richard, Fanny Ledys, et al.
Cancer Cell|January 20, 2022
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cellsEmeric Limagne, Lisa Nuttin, Marion Thibaudin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2022
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional studySylvain Ladoire, Emilie Rederstorff, Vincent Goussot, et al.
Pageof 11